On August 30, 2023 Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), reported that Bill Newell, Chief Executive Officer, will participate in two upcoming investor conferences (Press release, Sutro Biopharma, AUG 30, 2023, View Source [SID1234634780]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:

Citi 18th Annual BioPharma Conference
Format: Fireside Chat
Date: Wednesday, September 6, 2023
Time: 8:00 a.m. ET / 5:00 a.m. PT
Location: Boston

2023 Wells Fargo Healthcare Conference
Format: Fireside Chat
Date: Thursday, September 7, 2023
Time: 10:15 a.m. ET / 7:15 a.m. PT
Location: Boston

Webcasts of the fireside chats will be accessible through the News & Events page of the Investor Relations section of the company’s website at www.sutrobio.com. Archived replays will be available for at least 30 days after the event.